Retinal vein occlusion (RVO) represents the second most common retinal vascular disorder, after diabetic retinopathy, and remains a major cause of vision loss worldwide (1, 2). The condition arises from thrombotic obstruction of retinal venous outflow, leading to hemorrhage, ischemia, and macular edema (1, 3). Its clinical impact varies depending o